GoldenGolden
Advanced Search
BioNTech

BioNTech

BioNTech is a German company that develops immunotherapies for the treatment of cancer and other diseases.

Primarily focused on developing individualized cancer therapy, BioNTech is a biotechnology company located in Mainz, Germany.

Approach

Their method revolves around several platforms in medicine; mRNA Therapeutics, engineered cell therapies, antibodies, and small molecule immunomodulators. Coupled with their approach to patient specific needs, they have seen success in providing unique treatments.

  1. Sequencing patient's tumor
  2. Mapping of mutations
  3. Bioinformatic algorithms
  4. Selection of neoepitopes
Pipeline
COVID-19

BNT162 is BioNTech’s mRNA vaccine program aimed at preventing COVID-19 infection. It is the first product candidate from Project Lightspeed and leverages BioNTech’s proprietary mRNA platforms for infectious diseases, its fully-owned GMP manufacturing infrastructure for mRNA vaccine production, and its global clinical development capabilities, drawing on BioNTech’s network of global collaborators. BioNTech is partnered with Pfizer for co-development and distribution of BNT162 and with Fosun Pharma on the vaccine development in China.

Timeline

November 25, 2020
BioNTech and Shanghai Fosun Pharmaceutical says they will launch a Phase II clinical trial of BioNTech's experimental COVID-19 vaccine in China.
November 12, 2020
Commission approves contract with BioNTech-Pfizer alliance to ensure access to a potential vaccine

The European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further 100 million doses, to be supplied once a vaccine has proven to be safe and effective against COVID-19. Member States can decide to donate the vaccine to lower and middle-income countries or to re-direct it to other European countries.

Funding rounds

Patents

Products

People

Name
Role
LinkedIn

Özlem Türeci

Chief Medical Officer

Ryan Richardson

Chief Strategy Officer

Sean Marett

Chief Business and Chief Commercial Officer

Sierk Poetting

Chief Financial Officer and Chief Operating Officer

Ugur Sahin

Chief Executive Officer

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

BioNTech Corporate Video

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
By The Associated Press
October 15, 2021
AP NEWS
PORTLAND, Maine -- A federal appeals court has denied an emergency request to stop a COVID-19 vaccine mandate from going into effect in Maine.The rule, announced by Democratic Gov. Janet Mills, requires health care workers to get vaccinated against the disease by Oct.
Kyle LaHucik
September 30, 2021
FierceBiotech
What will BioNTech do after helping Pfizer make a COVID-19 vaccine that has been delivered to hundreds of millions of people worldwide? Biotech insiders and the general public alike now have an answer: A phase 2 study of a different mRNA in a vaccine for colorectal cancer.
Darrell Etherington
September 21, 2021
TechCrunch
Ultimately, BioNTech's mission is to make treatments that are optimized not only to specific patient needs, but also to time and place.
Arlene Weintraub
September 8, 2021
FierceBiotech
A BioNTech-led team designed a cocktail of mRNAs that instruct cells to produce four cancer-fighting molecules. The treatment suppressed tumors in mouse models of colon cancer and melanoma, and it worked even better when combined with checkpoint inhibiting drugs, they reported in a new study.
Annalee Armstrong
August 31, 2021
FierceBiotech
COVID-19 wasn't even in the picture when mRNA was developed, but with the regulatory runway cleared, biotechs that have been working on the tech for years are ready for liftoff. Yes, Moderna and BioNTech are the rock stars in the business--launched to household name status with the COVID-19 vaccines at the end of 2020. But there's more to the pipeline than just these headliners.
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.